539 related articles for article (PubMed ID: 16356188)
1. Differential direct effects of cyclo-oxygenase-1/2 inhibition on proteoglycan turnover of human osteoarthritic cartilage: an in vitro study.
Mastbergen SC; Jansen NW; Bijlsma JW; Lafeber FP
Arthritis Res Ther; 2006; 8(1):R2. PubMed ID: 16356188
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and release of human cartilage matrix proteoglycans are differently regulated by nitric oxide and prostaglandin-E2.
Mastbergen SC; Bijlsma JW; Lafeber FP
Ann Rheum Dis; 2008 Jan; 67(1):52-8. PubMed ID: 17485421
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of COX-2 by celecoxib in the canine groove model of osteoarthritis.
Mastbergen SC; Marijnissen AC; Vianen ME; Zoer B; van Roermund PM; Bijlsma JW; Lafeber FP
Rheumatology (Oxford); 2006 Apr; 45(4):405-13. PubMed ID: 16287921
[TBL] [Abstract][Full Text] [Related]
4. Cyclooxygenase 2-dependent prostaglandin E2 modulates cartilage proteoglycan degradation in human osteoarthritis explants.
Hardy MM; Seibert K; Manning PT; Currie MG; Woerner BM; Edwards D; Koki A; Tripp CS
Arthritis Rheum; 2002 Jul; 46(7):1789-803. PubMed ID: 12124863
[TBL] [Abstract][Full Text] [Related]
5. Selective COX-2 inhibition is favorable to human early and late-stage osteoarthritic cartilage: a human in vitro study.
Mastbergen SC; Bijlsma JW; Lafeber FP
Osteoarthritis Cartilage; 2005 Jun; 13(6):519-26. PubMed ID: 15922186
[TBL] [Abstract][Full Text] [Related]
6. Effects of R and S enantiomers and a racemic mixture of carprofen on the production and release of proteoglycan and prostaglandin E2 from equine chondrocytes and cartilage explants.
Armstrong S; Lees P
Am J Vet Res; 1999 Jan; 60(1):98-104. PubMed ID: 9918155
[TBL] [Abstract][Full Text] [Related]
7. Metabolism of human articular chondrocytes cultured in alginate beads. Longterm effects of interleukin 1beta and nonsteroidal antiinflammatory drugs.
Sanchez C; Mateus MM; Defresne MP; Crielaard JM; Reginster JY; Henrotin YE
J Rheumatol; 2002 Apr; 29(4):772-82. PubMed ID: 11950021
[TBL] [Abstract][Full Text] [Related]
8. Nonsteroidal antiinflammatory drugs in treatment of osteoarthritis.
Brandt KD; Slowman-Kovacs S
Clin Orthop Relat Res; 1986 Dec; (213):84-91. PubMed ID: 3780106
[TBL] [Abstract][Full Text] [Related]
9. Wound collagen deposition in rats: effects of an NO-NSAID and a selective COX-2 inhibitor.
Muscará MN; McKnight W; Asfaha S; Wallace JL
Br J Pharmacol; 2000 Feb; 129(4):681-6. PubMed ID: 10683192
[TBL] [Abstract][Full Text] [Related]
10. The chondroprotective effect of selective COX-2 inhibition in osteoarthritis: ex vivo evaluation of human cartilage tissue after in vivo treatment.
de Boer TN; Huisman AM; Polak AA; Niehoff AG; van Rinsum AC; Saris D; Bijlsma JW; Lafeber FJ; Mastbergen SC
Osteoarthritis Cartilage; 2009 Apr; 17(4):482-8. PubMed ID: 18926729
[TBL] [Abstract][Full Text] [Related]
11. Long-term NSAID treatment directly decreases COX-2 and mPGES-1 production in the articular cartilage of patients with osteoarthritis.
Alvarez-Soria MA; Herrero-Beaumont G; Moreno-Rubio J; Calvo E; Santillana J; Egido J; Largo R
Osteoarthritis Cartilage; 2008 Dec; 16(12):1484-93. PubMed ID: 18547825
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of NSAIDs on joint destruction in osteoarthritis.
Rainsford KD
Agents Actions Suppl; 1993; 44():39-43. PubMed ID: 8372733
[TBL] [Abstract][Full Text] [Related]
13. Nonsteroidal anti-inflammatory drug-activated gene-1 plays a role in the impairing effects of cyclooxygenase inhibitors on gastric ulcer healing.
Colucci R; Antonioli L; Bernardini N; Ippolito C; Segnani C; Awwad O; Tuccori M; Blandizzi C; Scarpignato C; Fornai M
J Pharmacol Exp Ther; 2012 Jul; 342(1):140-9. PubMed ID: 22495067
[TBL] [Abstract][Full Text] [Related]
14. The effects of non-selective, preferential-selective and selective COX-inhibitors on the growth of experimental and human tumors in mice related to prostanoid receptors.
Cahlin C; Gelin J; Andersson M; Lönnroth C; Lundholm K
Int J Oncol; 2005 Oct; 27(4):913-23. PubMed ID: 16142306
[TBL] [Abstract][Full Text] [Related]
15. Dose-dependent immunomodulatory effects of acetylsalicylic acid and indomethacin in human whole blood: potential role of cyclooxygenase-2 inhibition.
Härtel C; von Puttkamer J; Gallner F; Strunk T; Schultz C
Scand J Immunol; 2004 Oct; 60(4):412-20. PubMed ID: 15379866
[TBL] [Abstract][Full Text] [Related]
16. Celecoxib has a positive effect on the overall metabolism of hyaluronan and proteoglycans in human osteoarthritic cartilage.
El Hajjaji H; Marcelis A; Devogelaer JP; Manicourt DH
J Rheumatol; 2003 Nov; 30(11):2444-51. PubMed ID: 14677191
[TBL] [Abstract][Full Text] [Related]
17. Cyclooxygenase inhibition lowers prostaglandin E2 release from articular cartilage and reduces apoptosis but not proteoglycan degradation following an impact load in vitro.
Jeffrey JE; Aspden RM
Arthritis Res Ther; 2007; 9(6):R129. PubMed ID: 18096078
[TBL] [Abstract][Full Text] [Related]
18. Oral administration of the NADPH-oxidase inhibitor apocynin partially restores diminished cartilage proteoglycan synthesis and reduces inflammation in mice.
Hougee S; Hartog A; Sanders A; Graus YM; Hoijer MA; Garssen J; van den Berg WB; van Beuningen HM; Smit HF
Eur J Pharmacol; 2006 Feb; 531(1-3):264-9. PubMed ID: 16405885
[TBL] [Abstract][Full Text] [Related]
19. Curcumin synergistically potentiates the growth-inhibitory and pro-apoptotic effects of celecoxib in osteoarthritis synovial adherent cells.
Lev-Ari S; Strier L; Kazanov D; Elkayam O; Lichtenberg D; Caspi D; Arber N
Rheumatology (Oxford); 2006 Feb; 45(2):171-7. PubMed ID: 16249246
[TBL] [Abstract][Full Text] [Related]
20. Activation of diverse eicosanoid pathways in osteoarthritic cartilage: a lipidomic and genomic analysis.
Attur M; Dave M; Abramson SB; Amin A
Bull NYU Hosp Jt Dis; 2012; 70(2):99-108. PubMed ID: 22891999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
